AETERNUM HEALTH, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data AETERNUM HEALTH, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2024	FY2024	FY2025
Revenue	0				0.01	0.02	0.02	0.02	0.07	0.2
Cost of revenue						0.04		0.05
Gross profit						-0.02	-0.03	-0.04	-0.01	0.12
General and administrative		0.02	0	0.01	0.23	0.05	0.34	0.1	0.1	0.11
Operating expenses		0.06	0.04	0.03	0.31	0.24	0.52	0.55	0.42	0.39
Operating income	-0.05	-0.06	-0.04	-0.03	-0.3	-0.26	-0.55	-0.58	-0.43	-0.27
Interest expense	0	0			1.7	0.01	0.08	0.08	0.07	0.07
Other non-operating income	-0	-0			-1.77	-0.06	-0.08	-0.08	-0.02	-0.07
Income tax					0
Net income	-0.05	-0.06	-0.04	-0.03	-2.07	-0.32	-0.63	-0.66	-0.45	-0.34
EBITDA						-0.25
EPS, basic	-0.01	-0.02	-0.01	0.00	-0.36	-0.01	-0.01	-0.01	-0.01	-0.01
EPS, diluted	-0.01	-0.02	-0.01	0.00	-0.36	-0.01	-0.01	-0.01	-0.01	-0.01
Shares, basic (weighted)	3.51	3.51	3.51	3.51	5.75	47.1	42.5	48.1	48.5	49
Shares, diluted (weighted)	3.51	3.51	3.51	3.51	5.75	47.1	42.5	48.1	48.5	49

Balance sheet

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2024	FY2024	FY2025
Cash and equivalents	0	0	0	0	0	0	0	0	0	0
Receivables						0.05				0
Inventory						0.01	0.01	0.01	0.04	0.04
Other current assets						0		0.01	0
Total current assets	0	0				0.68	0.31	0.21	0.06	0.05
Other non-current assets						0	0	0	0	0
Total assets	0	0	0	0	0.21	0.68	0.31	0.21	0.07	0.05
Accounts payable	0.21	0.23	0.25	0.27	0.01	0.11	0.02	0.05	0.09	0.05
Total current liabilities	2.31	2.37	2.41	2.44	0.01	0.36	0.5	0.52	0.82	1.13
Long-term debt						1.18
Total liabilities	2.31	2.37	2.41	2.44	0.01	1.52	1.53	1.52	1.74	2.05
Paid-in capital	2.68	2.68	2.68	2.68	5.65	0.62	0.8	0.8	0.8	0.81
Retained earnings	-4.99	-5.05	-5.09	-5.12	-7.19	-1.91	-2.49	-2.58	-2.94	-3.28
Treasury stock	-0.04	-0.04	-0.04	-0.04	-0.04	-0.04	-0.04	-0.04	-0.04	-0.04
Shareholders' equity	-2.31	-2.37	-2.41	-2.44	-1.6	-0.85	-1.23	-1.31	-1.68	-2
Total equity	-2.31	-2.37	-2.41	-2.44	-1.6	-0.85	-1.23	-1.31	-1.68	-2
Total liabilities and equity	0	0	0	0	0.21	0.68	0.31	0.21	0.07	0.05
Shares outstanding	3.55			3.55	7.15	47.4	48.5	48.5	48.5	49.2

Cash flow statement

	FY2018	FY2020	FY2020	FY2021	FY2022	FY2023	FY2024	FY2024	FY2024	FY2025
Net income	-0.05	-0.06	-0.04	-0.03	-2.07	-0.32	-0.63	-0.66	-0.45	-0.34
Depreciation and amortization						0.01
Stock-based compensation					0.09		0.2			0.01
Change in receivables										-0
Change in inventory						-0	0	-0	-0.04	0.01
Change in payables	0.02	0.02	0.02	0.03	-0.05
Cash from operations	-0.04	-0.04	-0.02	-0	-0.12	-0.3	-0.27	-0.34	-0.15	-0
Cash from investing	0	0	0	0	0	-0.05
Stock issued					0.24	0.66	0.66
Cash from financing	0.04	0.04	0.02	0	0.3	0.65	0.55	-0.15	-0.11
Net change in cash	0	-0	0	-0	0.18	0.35	0.28	-0.49	-0.27	-0
Interest paid	0	0	0	0	0				0
Income taxes paid	0		0	0

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $0.12 on September 28, 2026.

Profitability

Metric	Value	How it is calculated
Return on assets (ROA)	69.8%	Net income / average total assets.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	212.7%	Revenue vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y	-16.6%	Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y	1.2%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Liabilities / assets	117.7%	Total liabilities / total assets.
Tangible book value	-$341.2K	Shareholders' equity - goodwill - intangible assets.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.02	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Operating cash flow per share	-$0.03	Cash from operations / diluted weighted shares.
Book value per share	-$0.01	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$0.01	Tangible book value / shares outstanding.
Cash per share	$0.00	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$11.7M	Share price x shares outstanding.
Enterprise value	$11.7M	Market cap + total debt - cash - short-term investments.
P/E	8.66x	Market cap / net income. Only when net income is positive.
Earnings yield	11.5%	Net income / market cap (the inverse of P/E).

What was AETERNUM HEALTH, INC.'s revenue in fiscal 2025?

AETERNUM HEALTH, INC. reported revenue of $203.7K for fiscal 2025, 212.7% higher than the year before.

Was AETERNUM HEALTH, INC. profitable in fiscal 2025?

No. It reported a net loss of $337.1K.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to AETERNUM HEALTH, INC.